ZONHONBIO is committed to the research and development of distinctive innovative drugs and improved drugs with independent intellectual property rights, targeting major indications such as central nervous system disorders, cardiovascular and pulmonary diseases, refractory solid tumors, and allergic respiratory diseases. We also focus on expanding the indications for the new drugs.